Cancer risk in patients with intestinal behçet’s disease: A nationwide population-Based study

Minkyung Han, Yoon Suk Jung, Won Ho Kim, Jae Hee Cheon, Sohee Park

Research output: Contribution to journalArticle

Abstract

Background/Aims: The relationship between intestinal Behçet’s disease (BD) and cancer remains unclear. We conducted a nationwide, population-based study to determine the risk of cancer in patients with intestinal BD. Methods: Using the National Health Insurance claims records, we collected data on 365 patients who had been diagnosed with intestinal BD between 2011 and 2014. Standardized incidence ratios (SIRs) of overall and site-specific cancers in patients with intestinal BD in comparison with the general population were calculated. Results: Among 167 men with intestinal BD, four cases of cancer were observed; among 191 women with BD, eight cases of cancer were observed. The risk of all cancers was significantly higher in women with intestinal BD than in women of the general population (SIR, 4.27; 95% confidence interval [CI], 1.84 to 8.41). However, in men with intestinal BD, the risk of all cancers was not significantly higher than that in men of the general population (SIR, 2.08; 95% CI, 0.57 to 5.33). The risk of hematologic cancer was significantly higher in both men and women with intestinal BD than in their counterparts in the general population (SIR, 23.90; 95% CI, 2.89 to 86.32 in men; SIR, 34.47; 95% CI, 4.17 to 124.51 in women). In particular, patients with intestinal BD showed a higher risk of leukemia and myelodysplastic syndrome than the general population. Conclusions: Patients with intestinal BD demonstrated a higher risk of hematologic cancer, especially leukemia, than the general population. Furthermore, women with intestinal BD showed a higher risk of all cancers.

Original languageEnglish
Pages (from-to)433-439
Number of pages7
JournalGut and liver
Volume12
Issue number4
DOIs
Publication statusPublished - 2018 Jul

Fingerprint

Intestinal Diseases
Population
Neoplasms
Confidence Intervals
Incidence
Leukemia
Intestinal Neoplasms
Myelodysplastic Syndromes
National Health Programs

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Han, Minkyung ; Jung, Yoon Suk ; Kim, Won Ho ; Cheon, Jae Hee ; Park, Sohee. / Cancer risk in patients with intestinal behçet’s disease : A nationwide population-Based study. In: Gut and liver. 2018 ; Vol. 12, No. 4. pp. 433-439.
@article{6fd74f711c0f4029992fa2167b09675c,
title = "Cancer risk in patients with intestinal beh{\cc}et’s disease: A nationwide population-Based study",
abstract = "Background/Aims: The relationship between intestinal Beh{\cc}et’s disease (BD) and cancer remains unclear. We conducted a nationwide, population-based study to determine the risk of cancer in patients with intestinal BD. Methods: Using the National Health Insurance claims records, we collected data on 365 patients who had been diagnosed with intestinal BD between 2011 and 2014. Standardized incidence ratios (SIRs) of overall and site-specific cancers in patients with intestinal BD in comparison with the general population were calculated. Results: Among 167 men with intestinal BD, four cases of cancer were observed; among 191 women with BD, eight cases of cancer were observed. The risk of all cancers was significantly higher in women with intestinal BD than in women of the general population (SIR, 4.27; 95{\%} confidence interval [CI], 1.84 to 8.41). However, in men with intestinal BD, the risk of all cancers was not significantly higher than that in men of the general population (SIR, 2.08; 95{\%} CI, 0.57 to 5.33). The risk of hematologic cancer was significantly higher in both men and women with intestinal BD than in their counterparts in the general population (SIR, 23.90; 95{\%} CI, 2.89 to 86.32 in men; SIR, 34.47; 95{\%} CI, 4.17 to 124.51 in women). In particular, patients with intestinal BD showed a higher risk of leukemia and myelodysplastic syndrome than the general population. Conclusions: Patients with intestinal BD demonstrated a higher risk of hematologic cancer, especially leukemia, than the general population. Furthermore, women with intestinal BD showed a higher risk of all cancers.",
author = "Minkyung Han and Jung, {Yoon Suk} and Kim, {Won Ho} and Cheon, {Jae Hee} and Sohee Park",
year = "2018",
month = "7",
doi = "10.5009/gnl17324",
language = "English",
volume = "12",
pages = "433--439",
journal = "Gut and Liver",
issn = "1976-2283",
publisher = "Joe Bok Chung",
number = "4",

}

Cancer risk in patients with intestinal behçet’s disease : A nationwide population-Based study. / Han, Minkyung; Jung, Yoon Suk; Kim, Won Ho; Cheon, Jae Hee; Park, Sohee.

In: Gut and liver, Vol. 12, No. 4, 07.2018, p. 433-439.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cancer risk in patients with intestinal behçet’s disease

T2 - A nationwide population-Based study

AU - Han, Minkyung

AU - Jung, Yoon Suk

AU - Kim, Won Ho

AU - Cheon, Jae Hee

AU - Park, Sohee

PY - 2018/7

Y1 - 2018/7

N2 - Background/Aims: The relationship between intestinal Behçet’s disease (BD) and cancer remains unclear. We conducted a nationwide, population-based study to determine the risk of cancer in patients with intestinal BD. Methods: Using the National Health Insurance claims records, we collected data on 365 patients who had been diagnosed with intestinal BD between 2011 and 2014. Standardized incidence ratios (SIRs) of overall and site-specific cancers in patients with intestinal BD in comparison with the general population were calculated. Results: Among 167 men with intestinal BD, four cases of cancer were observed; among 191 women with BD, eight cases of cancer were observed. The risk of all cancers was significantly higher in women with intestinal BD than in women of the general population (SIR, 4.27; 95% confidence interval [CI], 1.84 to 8.41). However, in men with intestinal BD, the risk of all cancers was not significantly higher than that in men of the general population (SIR, 2.08; 95% CI, 0.57 to 5.33). The risk of hematologic cancer was significantly higher in both men and women with intestinal BD than in their counterparts in the general population (SIR, 23.90; 95% CI, 2.89 to 86.32 in men; SIR, 34.47; 95% CI, 4.17 to 124.51 in women). In particular, patients with intestinal BD showed a higher risk of leukemia and myelodysplastic syndrome than the general population. Conclusions: Patients with intestinal BD demonstrated a higher risk of hematologic cancer, especially leukemia, than the general population. Furthermore, women with intestinal BD showed a higher risk of all cancers.

AB - Background/Aims: The relationship between intestinal Behçet’s disease (BD) and cancer remains unclear. We conducted a nationwide, population-based study to determine the risk of cancer in patients with intestinal BD. Methods: Using the National Health Insurance claims records, we collected data on 365 patients who had been diagnosed with intestinal BD between 2011 and 2014. Standardized incidence ratios (SIRs) of overall and site-specific cancers in patients with intestinal BD in comparison with the general population were calculated. Results: Among 167 men with intestinal BD, four cases of cancer were observed; among 191 women with BD, eight cases of cancer were observed. The risk of all cancers was significantly higher in women with intestinal BD than in women of the general population (SIR, 4.27; 95% confidence interval [CI], 1.84 to 8.41). However, in men with intestinal BD, the risk of all cancers was not significantly higher than that in men of the general population (SIR, 2.08; 95% CI, 0.57 to 5.33). The risk of hematologic cancer was significantly higher in both men and women with intestinal BD than in their counterparts in the general population (SIR, 23.90; 95% CI, 2.89 to 86.32 in men; SIR, 34.47; 95% CI, 4.17 to 124.51 in women). In particular, patients with intestinal BD showed a higher risk of leukemia and myelodysplastic syndrome than the general population. Conclusions: Patients with intestinal BD demonstrated a higher risk of hematologic cancer, especially leukemia, than the general population. Furthermore, women with intestinal BD showed a higher risk of all cancers.

UR - http://www.scopus.com/inward/record.url?scp=85049990257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049990257&partnerID=8YFLogxK

U2 - 10.5009/gnl17324

DO - 10.5009/gnl17324

M3 - Article

C2 - 29429154

AN - SCOPUS:85049990257

VL - 12

SP - 433

EP - 439

JO - Gut and Liver

JF - Gut and Liver

SN - 1976-2283

IS - 4

ER -